When exposed to a challenge of 10 Mycobacterium bovis BCG cells per antigen-presenting cell, most human monocytes engulf several organisms. In contrast, blood dendritic cells which are potent antigen-presenting cells for several antigens are not detectably phagocytic for mycobacteria. We investigated the possibility that infected macrophages might regurgitate antigens for presentation by populations of human blood dendritic cells. Macrophages were infected with M. bovis BCG, mixed with uninfected dendritic cells, and added to immune T cells, either bulk T cells or cloned populations from BCG vaccinees or patients recovering from tuberculosis. The macrophages were from donors who were mismatched to the T cells so that transfer of antigen to major histocompatibility complex-matched dendritic cells could be evaluated. As we describe, there was no evidence for the transfer of mycobacterial antigens from macrophages to dendritic cells in a form that was stimulatory for the T cells.
Antigen-presenting cells (APCs) play a central role in processing and presenting complex antigens, including infectious agents, to T cells. In the case of mycobacteria, macrophages phagocytose, process, and present antigens to primed T cells to evoke immune responses. In active tuberculosis (TB), however, macrophages also serve as sites for mycobacterial replication (17) . Chronically infected macrophages can in fact sequester mycobacteria from immune T cells-a phenomenon that may account for progression and persistence of mycobacterial disease (11) .
Another APC, the dendritic cell, has increasingly been studied as a class of APC that is specialized for inducing T-cell responses including responses in whole animals (18) . Yet, these APCs typically do not internalize particulate antigens (14, 19) . While it is clear that dendritic cells can present soluble microbial antigens effectively (8, 13) , it is unclear to what extent the dendritic cell itself processes determinants from particulate intracellular mycobacteria.
One possibility that has been repeatedly considered is that dendritic cells do not need to process the organism to serve as APCs, but instead acquire antigenic fragments that are regurgitated from phagocytic macrophages. Transfer of mycobacterial antigens from infected macrophages has been previously proposed as a mechanism for activating lymphocytes (3) . This possibility is of interest in the setting of the lung, where macrophages are not only suppressive for T-cell responses but also lie directly juxtaposed to dendritic cells in the airway epithelium (6) . In vivo, dendritic cells bearing antigens can migrate to distant sites and induce sensitization (10) . It therefore becomes important to know whether antigens can be acquired from the actively phagocytic macrophages.
To pursue the possibility of antigen transfer from infected macrophages to dendritic cells, we established two culture systems in which T cells were obtained from Mycobacterium bovis BCG vaccinees and TB patients. Major histocompatibility complex (MHC)-mismatched macrophages from human blood were infected with M. bovis BCG to provide a synthesizer and kindly supplied by P. J. Brennan (Fort Collins, Colo.). Purity of the peptide was checked by reverse-phase high-pressure liquid chromatography. The optimal concentration of peptide for T-cell proliferation was tested with peripheral blood mononuclear cells from an HLA-DR3-matched BCG vaccinee and was found to be 1 pLg/ml. Culture medium. RPMI 1640 (GIBCO, Grand Island, N.Y.) supplemented with 5% human AB' serum and ampicillin (100 ,ug/ml; Sigma Chemical Co., St. Louis, Mo.) was used for infecting APC with live M. bovis BCG. After infection, cells were cultured in 5% human serum-50 ,ug of gentamicin per ml (13) .
Preparation of T cells and APC. Blood mononuclear cells were rosetted with neuraminidase-treated sheep erythrocytes (E), and the ER' fraction was used as the source of T cells. Residual monocytes were depleted from the ER' fraction by being panned twice on immunoglobulin (Ig)-coated petri dishes (12) . APCs (monocytes and dendritic cells) were prepared from the ER-fraction as previously described (13) . In brief, monocytes were isolated by adherence to tissue culture plates for 1 h, at which time the nonadherent cells were collected. The adherent cells were washed vigorously with warm RPMI medium to remove any loosely adherent cells, after which the monocytes were dislodged with cold phosphate-buffered saline depleted of Ca2' and Mg2+. Dendritic cells were prepared from the T-cell-depleted, monocyte-depleted populations by additional panning on Ig-coated plates to remove residual contaminating monocytes. ER-FcR-cells were then sedimented on 14.5% metrizamide gradients to obtain a lowdensity fraction that is 40 to 60% dendritic cells (5) . Metrizamide pellets or sinkers were the source of B cells (13) . In experiments in which pure dendritic cells were required, nondendritic cells in the metrizamide low-density fraction were labeled with phycoerythrin-conjugated monoclonal antibodies (MAbs) to CD14 (macrophages), CD56 and CD16 (NK cells), and CD19 (B cells), and the unlabeled dendritic cells were purified by cell sorting with a FACStar Plus instrument (Becton Dickinson, Immunocytometry Systems, San Jose, Calif.) as previously described (5) . Cells that were large but failed to stain with this cocktail of MAbs were >95% dendritic cells. Adherent macrophages were sorted similarly after incubation with the above MAbs with the exception of anti-CD14.
MAbs. Anti-DR (L243; ATCC HB55), anti-DP (PL15; a gift from S. Y. Yang at Sloan Kettering Institute for Cancer Research), anti-DR and -DQ (9.3C9; ATCC HB180), and anti-DQ (ATCC HB103) were used. MAbs were purified from ascites fluid over protein G columns and used at a final concentration of 1 ,ug/ml. Isotype-matched, purified mouse IgGl and IgG2a (Sigma) were used as controls.
Infection of macrophages and dendritic cells. ER-cells, which contain macrophages, B cells, and dendritic cells, were pulsed with live M. bovis BCG for 12 to 14 h at a ratio of 5 to 10 viable mycobacteria per mononuclear cell. Cell suspensions were then washed three to five times (150 g; 10 min each) to remove extracellular mycobacteria. Purified populations of dendritic cells and macrophages were then isolated as described above. In some cases, purified populations of macrophages and dendritic cells were prepared first and then infected with BCG. To detect cell-associated acid-fast mycobacteria within APCs, infected macrophages and dendritic cells were cytospun onto glass slides, fixed in formalin, and stained with auramine-rhodamine in the dark. After being washed under running tap water and acid alcohol, slides were examined by fluorescence and phase-contrast microscopy.
Generation of mycobacterium-specific T-cell lines and clones. T-cell lines and clones were generated from dendritic cell-T-cell clusters after dendritic cells were pulsed with live mycobacteria as previously described (13 (12, 13) . The maintenance of antigen specificity of clones and lines to syngeneic APC infected with live mycobacteria was confirmed (see below). The use of the mitogen, sodium periodate, in both expanding and maintaining the antigen specificity of clones has been described previously, as has the use of dendritic cell-T-cell clusters to efficiently immunoselect mycobacterium-specific CD4+ T cells (13) . Systems to detect transfer of mycobacterial epitopes from infected macrophages to dendritic cells. T cells recognize antigens in the context of self MHC. To determine whether blood dendritic cells acquire antigens from infected macrophages, we designed experiments in which MHC-mismatched macrophages were first infected with M. bovis BCG, washed extensively, and mixed with uninfected MHCmatched dendritic cells and T cells. The latter were either purified bulk T cells or T-cell clones and lines derived from a BCG vaccinee (patient 2) or a TB patient (patient 1).
(i) Bulk T-cell system. Adherent macrophages that were syngeneic or HLA mismatched were infected with M. bovis BCG (APC/BCG ratio, 1:5) and plated at 2.5 x 104 per well as described above. Uninfected adherent cells served as controls. Two days later, infected and uninfected adherent cells were washed three times with RPMI medium by spinning plates at 200 x g for 2 min, with each cycle followed by gentle aspiration of the supernatants. Bulk (10 ,ug/ml) and PPD (10 P,/ml). After bound to BCG-pulsed dendritic cells (see Methods) were cloned directly on periodate-modified allogeneic feeders. This allows efficient production of clones following plating at just 0.3 to 1 cell per well as described previously (13) .
Many antigen-reactive T-cell clones were obtained by this method (Table 3) , most of which were CD4+8-. A stimulation index of > 10 was used as an initial criterion for selecting antigen-specific T-cell clones (13) . The T-cell clones proliferated strongly to M. bovis BCG-infected, syngeneic APCs (Table 3) and maintained antigen specificity even after perpetuation for several months. The cells were all HLA-DR restricted since proliferation was totally blocked by antibodies to HLA-DR but not by those to DQ and DP (Table 3 ). In an experiment in which the patient was HLA-DR4, DRw17, DRw52, and DRw53, two of the clones (ADCL14 and ADCL17) were activated by antigen presented by cells obtained from a group of other HLA-DR4-positive but not HLA-DR4-negative individuals (Table 3 ). These two clones remained DR4 restricted and retained responsiveness to To overcome these shortcomings with the bulk T-cell system, we generated T-cell clones from TB patients and BCG vaccinees by clustering bulk T cells with M. bovis BCG-pulsed dendritic cells. With this approach, T cells that have specificity for endogenous mycobacterial antigens are efficiently selected (13) . We confirmed that this was the case by determining proliferation of the clones to syngeneic macrophages exposed to live mycobacteria (Table 3) . Clones derived in this manner were mycobacterium reactive and CD4'. The clones were HLA-DR restricted and were not alloreactive (Table 3) . Two (Fig. 1) , and even then, it was not possible to determine whether the organism had been internalized.
In addition to the pathway whereby antigens might be regurgitated from phagocytic macrophages, dendritic cells may acquire antigens in other ways. It is known that, once pulsed with antigen, dendritic cells can retain that antigen in an immunogenic form for days (8, 15) . Since so few MHCpeptide complexes are required for T cells to be stimulated, particularly when dendritic cells are the APCs (1), one or two ingested organisms may suffice such that dendritic cells do not have to be phagocytosing large numbers of organisms to acquire sufficient antigen to stimulate immunity. Alternatively, the dendritic cells may acquire peptide fragments by uptake of soluble antigens during the original antigen pulse or infection. Previously, it has been proposed that complex antigens like M. tuberculosis are processed at the dendritic cell surface by ectoenzymes (9) or by extracellular proteases within a caseous focus. Additionally, dendritic cells may better phagocytose mycobacteria at an earlier stage in their life history than the one that has been studied with blood and lymphoid tissues. For example, in rat afferent lymph, isolated dendritic cells are not phagocytic but nevertheless contain a few large cytoplasmic inclusions (14) . Recently, it has been shown that murine bone marrow-derived dendritic cell progenitors phagocytose mycobacteria and are capable of sensitizing mice to these antigens when delivered in vivo (7) . Similarly, freshly isolated Langerhans cells and spleen dendritic cells are more phagocytic for particulate antigens than are cultured dendritic cells (16) . This suggests that dendritic cells may be phagocytic in vivo, for example, in tissues prior to entry into the afferent lymph or perhaps in tuberculous infected foci. All of these possibilities are in need of further study. In primary blood cell cultures, however, it appears that dendritic cells do not readily capture mycobacterial antigens from heavily infected macrophages.
